Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy

Bone

Volumn 95, Issue , 2017, Pages 47-54

  Ivaska, Kaisa K ^a   Huovinen, Ville ^a   Soinio, Minna ^b   Hannukainen, Jarna C ^a   Saunavaara, Virva ^a   Salminen, Paulina ^a   Helmiö, Mika ^a   Parkkola, Riitta ^a   Nuutila, Pirjo ^a,b   Kiviranta, Riku ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bariatric surgery; Bone markers; Bone turnover; Obesity; Type 2 diabetes (T2DM)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; C TERMINAL CROSSLINKED TELOPEPTIDE OF TYPE I COLLAGEN; COLLAGEN; N TERMINAL PROPEPTIDE OF TYPE I COLLAGEN; OSTEOCALCIN; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BARIATRIC SURGERY; BONE DENSITY; BONE MARROW; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GASTRIC BYPASS SURGERY; GLYCEMIC CONTROL; HUMAN; LUMBAR SPINE; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; SLEEVE GASTRECTOMY; SURGICAL TECHNIQUE; WEIGHT REDUCTION; BONE; CASE CONTROL STUDY; GASTRECTOMY; GLUCOSE BLOOD LEVEL; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BONE AND BONES; BONE DENSITY; BONE REMODELING; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS;

EID: 84995615136     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2016.11.001     Document Type: Article

References (43)

1. [1] Sjostrom, L., Review of the key results from the swedish obese subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J. Intern. Med. 273 (2013), 219–234.
2. [2] Brzozowska, M.M., Sainsbury, A., Eisman, J.A., Baldock, P.A., Center, J.R., Bariatric surgery, bone loss, obesity and possible mechanisms. Obes. Rev. 14 (2013), 52–67.
3. [3] Yu, E.W., Bone metabolism after bariatric surgery. J. Bone Miner. Res. 29 (2014), 1507–1518.
4. [4] Liu, C., Wu, D., Zhang, J.F., Xu, D., Xu, W.F., Chen, Y., Liu, B.Y., Li, P., Li, L., Changes in bone metabolism in morbidly obese patients after bariatric surgery: a meta-analysis. Obes. Surg. 26 (2016), 91–97.
5. [5] Scibora, L.M., Ikramuddin, S., Buchwald, H., Petit, M.A., Examining the link between bariatric surgery, bone loss, and osteoporosis: a review of bone density studies. Obes. Surg. 22 (2012), 654–667.
6. [6] Yu, E.W., Bouxsein, M.L., Putman, M.S., Monis, E.L., Roy, A.E., Pratt, J.S., Scott Butsch, W., Finkelstein, J.S., Two-year changes in bone density after roux-en-Y gastric bypass surgery. J. Clin. Endocrinol. Metab. 100 (2015), 1452–1459.
7. [7] Bruno, C., Fulford, A.D., Potts, J.R., McClintock, R., Jones, R., Cacucci, B.M., Gupta, C.E., Peacock, M., Considine, R.V., Serum markers of bone turnover are increased at six and 18 months after roux-en-Y bariatric surgery: correlation with the reduction in leptin. J. Clin. Endocrinol. Metab. 95 (2010), 159–166.
8. [8] Muschitz, C., Kocijan, R., Marterer, C., Nia, A.R., Muschitz, G.K., Resch, H., Pietschmann, P., Sclerostin levels and changes in bone metabolism after bariatric surgery. J. Clin. Endocrinol. Metab. 100 (2015), 891–901.
9. [9] Wucher, H., Ciangura, C., Poitou, C., Czernichow, S., Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers. Obes. Surg. 18 (2008), 58–65.
10. [10] Cao, J.J., Effects of obesity on bone metabolism. J. Orthop. Surg. Res., 6, 2011, 30 (799X-6-30).
11. [11] Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M.D., Pories, W., Fahrbach, K., Schoelles, K., Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004), 1724–1737.
12. [12] Angrisani, L., Santonicola, A., Iovino, P., Formisano, G., Buchwald, H., Scopinaro, N., Bariatric surgery worldwide 2013. Obes. Surg. 25 (2015), 1822–1832.
13. [13] Stemmer, K., Bielohuby, M., Grayson, B.E., Begg, D.P., Chambers, A.P., Neff, C., Woods, S.C., Erben, R.G., Tschop, M.H., Bidlingmaier, M., Clemens, T.L., Seeley, R.J., Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 154 (2013), 2015–2024.
14. [14] Nogues, X., Goday, A., Pena, M.J., Benaiges, D., de Ramon, M., Crous, X., Vial, M., Pera, M., Grande, L., Diez-Perez, A., Ramon, J.M., Bone mass loss after sleeve gastrectomy: a prospective comparative study with gastric bypass. Cir. Esp. 88 (2010), 103–109.
15. [15] Vilarrasa, N., de Gordejuela, A.G., Gomez-Vaquero, C., Pujol, J., Elio, I., San Jose, P., Toro, S., Casajoana, A., Gomez, J.M., Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy. Obes. Surg. 23 (2013), 2086–2091.
16. [16] Maggard-Gibbons, M., Maglione, M., Livhits, M., Ewing, B., Maher, A.R., Hu, J., Li, Z., Shekelle, P.G., Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA 309 (2013), 2250–2261.
17. [17] Pratt, J.S., Lenders, C.M., Dionne, E.A., Hoppin, A.G., Hsu, G.L., Inge, T.H., Lawlor, D.F., Marino, M.F., Meyers, A.F., Rosenblum, J.L., Sanchez, V.M., Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring) 17 (2009), 901–910.
18. [18] Helmio, M., Victorzon, M., Ovaska, J., Leivonen, M., Juuti, A., Jaser, N., Peromaa, P., Tolonen, P., Hurme, S., Salminen, P., SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg. Endosc. 26 (2012), 2521–2526.
19. [19] Helmio, M., Victorzon, M., Ovaska, J., Leivonen, M., Juuti, A., Peromaa-Haavisto, P., Nuutila, P., Vahlberg, T., Salminen, P., Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: a prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up. Scand. J. Surg. 103 (2014), 175–181.
20. [20] Honka, H., Koffert, J., Hannukainen, J.C., Tuulari, J.J., Karlsson, H.K., Immonen, H., Oikonen, V., Tolvanen, T., Soinio, M., Salminen, P., Kudomi, N., Mari, A., Iozzo, P., Nuutila, P., The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. J. Clin. Endocrinol. Metab., jc20144236, 2015.
21. [21] Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1997, 1183–1197.
22. [22] Halleen, J.M., Ylipahkala, H., Alatalo, S.L., Janckila, A.J., Heikkinen, J.E., Suominen, H., Cheng, S., Vaananen, H.K., Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif. Tissue Int. 71 (2002), 20–25.
23. [23] Paldanius, P.M., Ivaska, K.K., Hovi, P., Andersson, S., Vaananen, H.K., Kajantie, E., Makitie, O., The effect of oral glucose tolerance test on serum osteocalcin and bone turnover markers in young adults. Calcif. Tissue Int. 90 (2012), 90–95.
24. [24] Ivaska, K.K., Heliovaara, M.K., Ebeling, P., Bucci, M., Huovinen, V., Vaananen, H.K., Nuutila, P., Koistinen, H.A., The effects of acute hyperinsulinemia on bone metabolism. Endocr. Connect. 4 (2015), 155–162.
25. [25] Rissanen, J.P., Suominen, M.I., Peng, Z., Halleen, J.M., Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif. Tissue Int. 82 (2008), 108–115.
26. [26] Chopin, F., Garnero, P., le Henanff, A., Debiais, F., Daragon, A., Roux, C., Sany, J., Wendling, D., Zarnitsky, C., Ravaud, P., Thomas, T., Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann. Rheum. Dis. 67 (2008), 353–357.
27. [27] Provencher, S.W., Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30 (1993), 672–679.
28. [28] Cohen, A., Dempster, D.W., Recker, R.R., Lappe, J.M., Zhou, H., Zwahlen, A., Muller, R., Zhao, B., Guo, X., Lang, T., Saeed, I., Liu, X.S., Guo, X.E., Cremers, S., Rosen, C.J., Stein, E.M., Nickolas, T.L., McMahon, D.J., Young, P., Shane, E., Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: A transiliac bone biopsy study. J. Clin. Endocrinol. Metab. 98 (2013), 2562–2572.
29. [29] Viljakainen, H., Ivaska, K.K., Paldanius, P., Lipsanen-Nyman, M., Saukkonen, T., Pietilainen, K.H., Andersson, S., Laitinen, K., Makitie, O., Suppressed bone turnover in obesity: A link to energy metabolism? A case-control study. J. Clin. Endocrinol. Metab. 99 (2014), 2155–2163.
30. [30] Evans, A.L., Paggiosi, M.A., Eastell, R., Walsh, J.S., Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J. Bone Miner. Res. 30 (2015), 920–928.
31. [31] Zaidi, M., Buettner, C., Sun, L., Iqbal, J., Minireview: the link between fat and bone: does mass beget mass?. Endocrinology 153 (2012), 2070–2075.
32. [32] Scheller, E.L., Rosen, C.J., What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann. N. Y. Acad. Sci. 1311 (2014), 14–30.
33. [33] Yu, E.W., Wewalka, M., Ding, S.A., Simonson, D.C., Foster, K., Holst, J.J., Vernon, A., Goldfine, A.B., Halperin, F., Effects of gastric bypass and gastric banding on bone remodeling in obese patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 101 (2016), 714–722.
34. [34] Henriksen, D.B., Alexandersen, P., Hartmann, B., Adrian, C.L., Byrjalsen, I., Bone, H.G., Holst, J.J., Christiansen, C., Four-month treatment with GLP-2 significantly increases hip BMD: A randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD. Bone 45 (2009), 833–842.
35. [35] Nissen, A., Christensen, M., Knop, F.K., Vilsboll, T., Holst, J.J., Hartmann, B., Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans. J. Clin. Endocrinol. Metab. 99 (2014), E2325–E2329.
36. [36] Pittas, A.G., Harris, S.S., Eliades, M., Stark, P., Dawson-Hughes, B., Association between serum osteocalcin and markers of metabolic phenotype. J. Clin. Endocrinol. Metab. 94 (2009), 827–832.
37. [37] Kanazawa, I., Yamaguchi, T., Yamauchi, M., Yamamoto, M., Kurioka, S., Yano, S., Sugimoto, T., Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos. Int. 22 (2011), 187–194.
38. [38] Shanbhogue, V.V., Mitchell, D.M., Rosen, C.J., Bouxsein, M.L., Type 2 diabetes and the skeleton: new insights into sweet bones. Lancet Diabetes Endocrinol. 4 (2016), 159–173.
39. [39] Yu, E.W., Bouxsein, M.L., Roy, A.E., Baldwin, C., Cange, A., Neer, R.M., Kaplan, L.M., Finkelstein, J.S., Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J. Bone Miner. Res. 29 (2014), 542–550.
40. [40] Schafer, A.L., Weaver, C.M., Black, D.M., Wheeler, A.L., Chang, H., Szefc, G.V., Stewart, L., Rogers, S.J., Carter, J.T., Posselt, A.M., Shoback, D.M., Sellmeyer, D.E., Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J. Bone Miner. Res. 30 (2015), 1377–1385.
41. [41] Adams, J.E., Quantitative computed tomography. Eur. J. Radiol. 71 (2009), 415–424.
42. [42] Devlin, M.J., Rosen, C.J., The bone-fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol. 3 (2015), 141–147.
43. [43] Schafer, A.L., Li, X., Schwartz, A.V., Tufts, L.S., Wheeler, A.L., Grunfeld, C., Stewart, L., Rogers, S.J., Carter, J.T., Posselt, A.M., Black, D.M., Shoback, D.M., Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: a pilot study. Bone 74C (2015), 140–145.